Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Financials · Hospital & Medical Service Plans

New Enterprise Associates, Inc. to acquire NeueHealth, Inc.

Announced Dec 23, 2024 · Closed Oct 2, 2025

Deal value$1.30B
Premium70.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$7.33 per share

Transaction

Acquirer
New Enterprise Associates, Inc.
Target
NeueHealth, Inc. (NEUE)
Buyer type
Strategic
Offer price per share
$7.33
Enterprise value
—
Status
Closed Oct 2, 2025

Deal protections

Break fee (target pays)
—
Reverse fee (buyer pays)
—
Go-shop
Go-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
Lincoln International

Sector context · Financials

Comparable deals
58 in the prior 24 months
Premium
70.0% vs. 33.5% sector median
EV / Adj. EBITDA
Sector median 13.7x
Break fee
Sector median 3.3%

Timeline

  1. AnnouncedDec 23, 2024
  2. Proxy filedFeb 3, 2025
  3. Definitive proxyApr 14, 2025
  4. Shareholder voteMay 7, 2025
  5. ClosedOct 2, 2025
Sources
  • 8-K · Dec 23, 2024

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.